MENU

Where I would invest $10,000 in the share market

With some economists now predicting that the Reserve Bank of Australia will keep interest rates on hold until 2020, now could be an opportune time to consider putting your money to work in the share market.

If I had $10,000 sitting in a savings account I would consider investing it in one of these three ASX shares:

Aristocrat Leisure Limited (ASX: ALL)

I think that this gaming technology company is one of the best growth shares on the local market and trading at a very reasonable price considering its growth profile. As well as having a strong and growing core pokie machine business, the company has begun to grow its presence significantly in the social and mobile gaming market through a couple of sizeable acquisitions. I believe these acquisitions will provide it with a portfolio of games and a talented development team that will lead to above-average growth from the segment over the next decade.

Macquarie Telecom Group Ltd. (ASX: MAQ)

I think this provider of telecommunication and hosting services to corporate and government customers doesn’t get the attention it deserves from the investment community. Especially considering the strong performance and growth potential of its data centre business. I think Macquarie Telecom is a cheaper alternative to market darling Nextdc Ltd (ASX: NXT), which I would also consider to be a buy today.

ResMed Inc. (CHESS) (ASX: RMD)

ResMed is a global healthcare company that specialises in the treatment of sleep apnoea and other chronic respiratory diseases. I think that RedMed could have a very bright future ahead of it thanks to its position as a market-leader in an industry which is expected to grow strongly over the long-term. I believe this puts it in a position to deliver above-average earnings growth and strong share price returns for shareholders for many years to come.

3 Top Shares To Invest Your Next $10,000 Into.

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2018."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor James Mickleboro owns shares of NEXTDC Limited. The Motley Fool Australia has recommended ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…

Including:

The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!